ISSN: 2155-952X

Journal of Biotechnology & Biomaterials
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • J Biotechnol Biomater 2022, Vol 12(3): 265
  • DOI: 10.4172/2155-952X.1000265

The Use of Intranasal Versus Intravenous Route to Limit Adverse Effects of Amphotericin B Administration

Naveed Ahmed Khan1*, Ruqaiyyah Siddiqui1 and Timothy Yu Yee Ong2
1Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences, American University of Sharjah, University City, Sharjah, United Arabic Emirates
2Department of Biological Sciences, School of Science and Technology, Sunway University, Bandar Sunway, Malaysia
*Corresponding Author : Naveed Ahmed Khan, Department of Biology, Chemistry and Environmental Sciences, College of Arts and Sciences, American University of Sharjah, University City, Sharjah, United Arab Emirates, United Arab Emirates, Email: naveed5438@gmail.com

Received Date: Jun 08, 2020 / Published Date: Mar 28, 2022

Abstract

Infection due to Naegleria fowleriis devastating and results in death within days, with more than a 90% mortality rate. The current mode of treatment is via intravenous therapy and is not very effective. For the first time, we tested the modality of the intranasal route to treat this deadly brain infection versus the intravenous route, post-infection in vivo. We compared the adverse effects of Amphotericin B administration, through blood biochemistry, liver, kidney and brain histopathological evidence of toxicities in both scenarios. The findings clearly depicted that intranasal administration of Amphotericin B, in comparison to the intravenous route significantly limited the adverse side effects in vivo. As N. fowleri exhibits unequivocal affinity to the olfactory bulb and frontal lobe in the central nervous system and the fact that parasite portal of entry is via nose, intranasal administration of therapy may be able to directly reach amoebae bypassing the blood-brain barrier selectivity and achieve the minimum inhibitory concentration at the target site. These findings are very encouraging and could lead to the development of a much needed new mode of therapy for this distressing infection. This work is pioneering, and could be a key step in the rationale development of therapeutic interventions against brain-eating amoebae infections by highlighting the use of the intranasal route as a modality to treat this normally fatal infection.

Citation: Khan NA, Siddiqui R, Ong TYY (2022) The Use of Intranasal Versus Intravenous Route to Limit Adverse Effects of Amphotericin B Administration. J Biotechnol Biomater, 12: 266. Doi: 10.4172/2155-952X.1000265

Copyright: © 2022 Khan NA, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top